Pancreatic Cancer Research

ResearcherShenzhen UniversityActive in the last 2 years

Xiushen Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7135-7299; OpenAlex author ID A5067593379. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. CD105+CAF-derived exosomes CircAMPK1 promotes pancreatic cancer progression by activating autophagy. First author DOI 10.1186/s40164-024-00533-3↗
  2. Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis. Co-author DOI 10.3389/fonc.2023.1119763↗
  3. The Senescence-Related Signature Predicts Prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic Cancer. Co-author DOI 10.1155/2022/1916787↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shiyu Chen · 1 shared paper, 2024 · strength 0.26
  2. Kun Cai · 1 shared paper, 2024 · strength 0.26
  3. Hui Liu · 1 shared paper, 2024 · strength 0.26
  4. Zhiwei He · 1 shared paper, 2024 · strength 0.26
  5. Xiaowu Li · 1 shared paper, 2024 · strength 0.26
  6. Zhiwei He · 1 shared paper, 2023 · strength 0.20
  7. Hui Liu · 1 shared paper, 2023 · strength 0.20
  8. Chao Yu · 1 shared paper, 2022 · strength 0.17
  9. Hao Hua · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.